Virbac S.A.
VRBCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3 | $2 | $3 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | $2 | $3 | $3 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 12.1% | 2.5% | 14.3% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 67.1% | 64.9% | 65.4% | 67% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 19.8% | 18.5% | 18% | 19.6% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 10.4% | 9.7% | 10% | 10.6% |
| EPS Diluted | 17.34 | 14.38 | 14.43 | 13.4 |
| % Growth | 20.6% | -0.3% | 7.7% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |